We have previously reported that transduction of murine colon cancer cells (MC38) with herpes simplex virus thymidine kinase (HSV-tk) gene results in a significant enhancement of tumor growth rate in vivo and overexpression of cyclooxygenase-2 (COX-2). Our current study aimed to investigate the involvement of nuclear factor-kappa B (NF-kB), a pivotal transcriptional regulator of COX-2, in the upregulation of COX-2 expression by HSV-tk. It was found that HSV-tk gene transduction of MC38 cells results in significantly enhanced NF-kB activity, increased phosphorylation and degradation of inhibitor-kappa Ba (IkBa) and enhanced translocation of NF-kB to the nucleus. Treatment of HSV-tk-transduced MC38 cells with sulfasalazine, a potent NF-kB inhibitor, led to dose-dependent inhibition of NF-kB activity, IkB phosphorylation and nuclear translocation of NF-kB, accompanied by significantly decreased COX-2 expression and reduced release of prostaglandin E 2 . Transient transfection experiments with COX-2 promoter constructs fused to luciferase reporter gene revealed that mutation in NF-kB-responsive element of COX-2 promoter significantly reduced promoter activity in HSV-tk-transduced MC38 and COS-7 cells, whereas it had no effect on promoter activity in the respective wild-type cells. At last, it was found that HSV-tk gene transduction causes significant enhancement of NF-kB activity and COX-2 expression in two additional tumor cell lines, 9L and T24. These findings suggest that HSV-tk gene transduction results in NF-kB pathway activation, which is essential for COX-2 overexpression by HSV-tk.
Introduction
Transduction of tumor cells with herpes simplex virus thymidine kinase (HSV-tk) gene and subsequent treatment with the nucleoside analog ganciclovir (GCV) is one of the most common 'suicide' gene therapy systems utilized to accomplish tumor cell killing. 1, 2 This approach has several limitations, such as low transduction efficiency, 3 vector cytotoxicity 4 and resistance or loss of GCV sensitivity. 5, 6 Additionally, we have previously reported that HSV-tk gene transduction of murine colon cancer (MC38) cells results in a significant enhancement of tumor growth rate in syngeneic mice as well as increased cyclooxygenase-2 (COX-2) expression and activity in vitro and in vivo. 7 We proposed that the latter might occur via activation of the nuclear factor-kappa B (NF-kB) pathway, which often plays an essential role in the upregulation of COX-2 expression during carcinogenesis. Thus, our current study aimed to investigate the effect of HSVtk gene transduction on NF-kB activity and the involvement of NF-kB in COX-2 overexpression previously observed in HSV-tk-transduced MC38 cells. 7 NF-kB comprises a family of the most ubiquitous eucaryotic transcription factors that serve as important regulators of the host inflammatory and immune response. NF-kB complex is a heterodimer, consisting of subunits of Rel family (Rel A or p65, p50, p52, c-Rel, v-Rel and Rel B), which is retained in the cytoplasm of unstimulated cells by binding to inhibitory proteins, known as IkB (IkBa, IkBb, IkBe, p105 and p100). 8 Upon activation by a variety of stimuli, such as viral and bacterial pathogens, cytokines, growth factors and stressinducing agents, IkB kinases (IKKa, IKKb and IKKg) phosphorylate IkB, resulting in IkB ubiquitylation and degradation by the proteasome. 8 The degradation of IkB unmasks nuclear localization sequence of NF-kB and allows NF-kB complex to translocate to the nucleus and bind to kB-responsive elements, located within the regulatory sequences of over 100 target genes including inflammatory cytokines, chemokines, growth factors, cell adhesion proteins and cytokine receptors. [8] [9] [10] Possible involvement of NF-kB in carcinogenesis has been initially suggested when the c-Rel member of NF-kB family was identified as a cellular homologue of the v-Rel oncogene, indicating that other members of this family are potential oncogenes. 11 Numerous studies have demonstrated that activation of NF-kB pathway plays crucial roles in the processes of tumor initiation 12, 13 and promotion. 14, 15 It has also been shown that a variety of human tumor cell lines possess constitutively active NF-kB, which contributes to enhanced survival of tumor cells, 16 resistance to apoptosis, 17, 18 tumor invasion, metastasis and angiogenesis. 19 A remarkably large number of studies conducted during the past decades revealed that COX-2, a key enzyme in the biosynthesis of prostaglandins, is implicated in the pathophysiology of human malignant disease and represents a promising target in the prevention and treatment of cancer. Overexpression of COX-2 and increased production of COX-2-derived prostaglandins has been associated with increased tumor growth, 20 invasiveness, 21 resistance to chemotherapy or radiation, 22, 23 increased production of proangiogenic factors, 24 resistance to apoptosis 25 and enhanced metastatic potential. 26 Although regulation of COX-2 expression during carcinogenesis is complex and appears to involve diverse mechanisms in different cell types, the fact that the 5 0 -flanking region of the COX-2 promoter contains two putative NF-kB binding sites 27 suggests a role for NF-kB pathway in the molecular regulation of COX-2 expression. Several reports have demonstrated that cancer-associated COX-2 overexpression is mediated by NF-kB. 28 ,29 NF-kB has been shown to be a positive regulator of COX-2 expression stimulated by tumor promoters, endotoxins and cytokines, such as phorbol 12-myristate 13-acetate, 30 hypoxia, 31 double-stranded RNA and viral infection, 32 bacterial lipopolysaccharide, 33 interleukin-1b 34 and tumor necrosis factor-a. 35 Anticancer properties of certain anti-inflammatory drugs, such as aspirin, have been primarily attributed, at least in a part, to their ability to decrease the synthesis of prostaglandins by inhibiting the catalytic activity of the COX-2 enzyme. 36 However, more recently, these agents have been found to exert their action at the level of transcription as well, through suppression of NF-kBdependent COX-2 expression. [37] [38] [39] Thus, the NF-kB pathway appears to be a prominent regulatory pathway that controls COX-2 expression during carcinogenesis.
This study was undertaken in an attempt to reveal the molecular mechanism underlying COX-2 overexpression following HSV-tk gene transduction, which was described in detail in our previous report. 7 We demonstrate herein that HSV-tk gene transduction of murine colon cancer cells results in enhanced activity of NF-kB pathway, which subsequently leads to COX-2 overexpression.
Materials and methods

Chemicals
Sulfasalazine (SFZ), 5-[4-(2-pyridylsulfamoyl)phenylazo]-salicylic acid, was purchased from Sigma (St Louis, MO) and prepared fresh on the day of each experiment. The drug was dissolved in dimethylsulfoxide to prepare a 100 mM stock solution and was later diluted with culture medium to the desired working concentration. All other reagents and chemicals were of the highest quality available.
Cell culture
The 3-methylcholanthrene-induced murine colon adenocarcinoma cells (MC38) were a generous gift of SA Rosenberg (NCI, USA). Rat gliosarcoma (9L) cells were provided by the Clinical Gene Therapy Branch, NIH, USA. Human urinary bladder cancer cells (T24) and African green monkey kidney cells (COS-7) were obtained from ATCC (ATCC numbers HTB-4 and CRL-1651, respectively). Cells were cultured in Dulbecco's modified Eagle's medium with 4.5 g/l D-glucose (Biological Industries, Beit Haemek, Israel), supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin and 10% fetal calf serum. Cells were maintained at 371C in a humidified atmosphere of 95% air and 5% CO 2 .
Retroviral vectors and tumor cell transduction
Vector producer cell lines (PA317/STK and PA317/ LNL6) were provided by the Clinical Gene Therapy Branch, NIH, USA. STK and LNL6 retroviral vectors have been described. 1, 7 To construct an STK vector, HSV-tk sequence was inserted into LNL6 vector, harboring the neomycin resistance (Neo R ) gene, which encodes for neomycin phosphotransferase II and confers resistance to the neomycin analog G418. MC38 cells transduced with HSV-tk (MC38/HSV-tk) or Neo R gene (MC38/Neo R ) as well as HSV-tk-transduced COS-7 cells (COS-7/HSV-tk) were generated by stable transduction of wild-type cells as previously described. 1 Briefly, PA317/ STK and PA317/LNL6 cells were cultured to 90% confluence for 24 h. Supernatant medium was then filtered through a 0.45 mm filter, supplemented with 8 mg/ml polybrene (hexadimethrine bromide; Sigma) and applied to target cells for 48 h with changing every 12 h. Thereafter, transduced cells were exposed to 1 mg/ml G418 (Geneticin, Life Technologies, Grand Island, NY) for 2 weeks to select for cells expressing vector-derived genes.
Plasmids and transient transfection pNFkB-Luc plasmid, which contains four tandem copies of the NF-kB promoter consensus sequence fused to the firefly luciferase gene, as well as the control pRL-TK plasmid, which contains Renilla luciferase gene driven by thymidine kinase promoter, were kindly provided by N Isakov (Department of Microbiology and Immunology, Ben-Gurion University, Israel). COX-2 promoter constructs, containing either native (À966/ þ 23) murine COX-2 promoter (pGL3C2-C1) or COX-2 promoter with mutated NF-kB-responsive element (pGL3C2-C7) cloned into pGL3-basic luciferase expression vector (Promega, Madison, WI), were generous gift of B Wingerd (Department of Biochemistry, Michigan State University, East Lansing, MI). In the mutant COX-2 promoter construct, binding of the active NF-kB to its consensus element was prevented by changing wild-type NF-kB sequence from GGGGATTCCC to GGGCCTTCCC. For transfection, wild-type and HSV-tk-transduced MC38 and COS-7 cells were seeded in six-well culture plates at 15 Â 10 4 cells/well and cultured overnight. Thereafter, cells were transiently transfected with either pNFkB-Luc (1.5 mg/well) or one of the COX-2 promoter constructs (2 mg/well). Transient transfection was performed in serum-free medium using Lipofectine reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. pRL-TK plasmid (0.05 mg/well) was co-transfected with the designated plasmid DNA to allow transfection efficiency control.
Dual luciferase assay
Transfected cells were cultured for 24-48 h in triplicate. Thereafter, firefly and Renilla luciferase activities were measured sequentially in cell lysates using a commercially available enzymatic assay (Dual Luciferase Reporter Assay System; Promega) according to the manufacturer's protocol. Measurements were performed in a TD-20/20 single-tube luminometer (Turner Designs, Sunnyvale, CA). The values of firefly luciferase activity were normalized to Renilla luciferase activity by determining the ratio of firefly luciferase activity over Renilla luciferase activity. Each experiment was repeated three times for reproducibility.
Western blot analysis
Western blot analysis was performed as previously described, 7 with slight modifications. Total cell lysates were obtained by scraping cells (1.5 Â 10 7 ) into 200 ml of ice-cold lysis buffer (50 mM Tris-HCl pH 7.5, 1 mM EDTA, 1 mM EGTA, 50 mM sodium fluoride, 0.1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM leupeptin, 20 m/ml aprotinin and 1 mM sodium vanadate). Cells were incubated on ice for 10 min to allow lysis and then centrifuged at 12 000 g for 10 min at 41C. For immunoblotting with phospho-specific antibodies, an initial lysis buffer was supplemented with 20 mM p-nitrophenyl phosphate (Sigma), which serves as a substrate for cellular phosphatases. Separation of cytosolic and nuclear fractions was performed as described in detail by Tohgo et al. 40 Briefly, cell lysates were centrifuged at 500 g, 41C for 5 min to pellet nuclei. The supernatants were used as the cytosolic fraction, whereas pellets, containing cell nuclei, were washed once in lysis buffer and pelleted again at 500 g. The resulting pellet was resuspended in lysis buffer and used as the nuclear fraction. Protein concentration in samples was determined by the Lowry method. 41 Thereafter, aliquots of cell lysates, reconstituted with an appropriate amount of 3 Â Laemmli's loading buffer, were resolved on 10% SDSpolyacrylamide minigels along with 5 ml of molecular weight standards (Fermentas, Hanover, MD) and transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA) by electroblotting. Membranes were incubated overnight at 41C with either anti-COX-2 (BD Transduction Laboratories, Franklin Lakes, NJ), Ser32/36 phosphospecific anti-p-IkBa, anti-IkBa (both from Cell Signaling, Beverly, MA) or anti-p65 (Santa-Cruz Biotechnology, Santa Cruz, CA) monoclonal IgG followed by incubation with either anti-rabbit or anti-mouse IgG, peroxidaselinked whole antibody (Santa-Cruz) for 90 min. The immunocomplexes were visualized by the ECL chemiluminescence method (Pierce, Rockford, IL) using exposure to Super RX film (Fuji Photo Film, Japan) for 5 min. To confirm equal loading in all lanes, membranes were blotted with either anti-b-actin (Sigma) or anti-a-tubulin (Oncogene, San Diego, CA) monoclonal antibodies. Quantitation of the immunoblots was performed by densitometric scanning using 202D Bio Imaging System (Pharmacia Biotech) with a Fujifilm Thermal Imaging System FTI-500 (Fuji, Japan) and TINA software (Raytest, Germany).
Prostaglandin E 2 measurement
Prostaglandin E 2 (PGE 2 ) that was released into the culture medium was measured by radioimmunoassay (RIA), which allows accurate measurement of PGE 2 in the sample (at the range of 0.075-20 ng/ml) as described in detail by Danon et al. 42 Briefly, medium samples (100 ml) were collected from the appropriate incubations and mixed with 500 ml of RIA assay buffer (containing K 2 HPO 4 10 mM, KH 2 PO 4 1 mM, 0.9% sodium chloride, 0.1% sodium azide and 0.1% bovine serum albumin, pH 7.4), containing an appropriate amount of reconstituted antiserum. The mixture was incubated at 41C for 30 min and 100 ml of radiolabeled PGE 2 was added. Tubes were incubated at 41C for 1 h, and then a cold charcoal-dextran suspension was added (0.2 ml). Ten minutes later, the tubes were centrifuged at 3500 r.p.m. for 10 min at 41C. Radioactivity in the supernatants was then measured by scintillation spectrometry. Percent binding of radiolabeled PGE 2 was compared to a standard curve and the amount of PGE 2 in the samples was calculated.
Statistical analysis
Results are expressed as means7s.e. Statistical evaluation was carried out using Student's t-test (two-tailed) to test for differences between the control and experimental results. Values of Po0.05 were considered statistically significant.
Results
Effect of HSV-tk gene transduction on NF-kB transcriptional activity
To analyze the effect of HSV-tk gene transduction on the transcriptional activity of NF-kB, we performed luciferase reporter gene assay using NF-kB-dependent luciferase expression vector (pNFkB-Luc). MC38, MC38/Neo R and MC38/HSV-tk cells were transiently transfected with pNFkB-Luc and, thereafter, assayed for luciferase activity. Figure 1 shows that HSV-tk gene transduction of MC38 cells led to significant enhancement of reporter activity, 4.3-fold increase over the basal reporter activity observed in wild-type MC38 cells. By contrast, transduction of MC38 cells with control vector, which harbors Neo R gene and differs from STK vector, used for HSV-tk gene delivery, only by lacking HSV-tk sequence, had no effect on the reporter activity ( Figure 1 ). These findings suggest that HSV-tk gene transduction of MC38 cells results in increased transcriptional activity of NF-kB.
Effect of HSV-tk gene transduction on IkB phosphorylation, degradation and nuclear translocation of NF-kB In order to find out whether enhanced NF-kB transcriptional activity, observed in HSV-tk-transduced MC38 cells, requires phosphorylation and degradation of IkB followed by nuclear translocation of NF-kB complex, we performed Western blot analysis. Using phospho-specific anti-IkBa antibody, we found that although a basal level of IkBa phosphorylation is present in wild-type MC38 cells, HSV-tk gene transduction significantly (B2-fold) enhanced IkBa phosphorylation (Figure 2a ). Because IkB phosphorylation generally results in the rapid degradation of IkB by proteasome, we assessed the expression of total IkBa in MC38 and MC38/HSV-tk cells. Figure 2b shows that HSV-tk gene transduction reduced the expression of total IkBa, indicating that enhanced IkBa phosphorylation in MC38/HSV-tk cells is followed by degradation of IkBa. Then, we evaluated the effect of HSV-tk gene transduction on the nuclear translocation of NF-kB complex by analyzing the expression of the p65 subunit of NF-kB consecutively in cytosolic and nuclear extracts prepared from MC38 and MC38/HSV-tk cells. As shown in Figure 2c and d, MC38/HSV-tk cells exhibited a significant (two-fold) increase in p65 expression within the nucleus, accompanied by reduction of p65 expression in the cytosol as compared with the wild-type MC38 cells. Altogether, these findings suggest that increased NF-kB transcriptional activity, observed in MC38/HSV-tk cells, is apparently a result of enhanced activation of the canonical NF-kB pathway, which requires IkB phosphorylation, degradation and translocation of NF-kB complex to the nucleus.
Effect of SFZ on NF-kB activity, IkB phosphorylation, degradation and nuclear translocation of NF-kB The ability of SFZ, a pharmacological inhibitor of NFkB, to affect the activity of NF-kB pathway under our experimental conditions was tested. It was found that treatment of MC38 and MC38/HSV-tk cells with increasing concentrations of SFZ (0.1, 0.5, 1 mM) led to dose-dependent reduction in NF-kB transcriptional activity, measured by reporter gene assay (Figure 3 ). Maximal inhibitory effect of SFZ (1 mM) on NF-kB activity was more substantial in MC38/HSV-tk cells, whereas basal activity of NF-kB pathway seen in wild-type MC38 cells was affected to a much lesser extent (32% inhibition in MC38 vs 51% in MC38/HSV-tk). Western blot analysis showed that treatment of MC38/HSV-tk cells with SFZ yielded dose-dependent inhibition of IkBa phosphorylation and, therefore, prevented successive degradation of IkBa, resulting in the accumulation of total, nonphosphorylated IkBa (Figure 4a and b) . Subsequently, SFZ inhibited nuclear translocation of NF-kB by retaining NF-kB complexes in the cytosol, as confirmed by dose-dependent decrease of nuclear p65 expression, accompanied by reciprocal changes in p65 expression in the cytosolic fraction of SFZ-treated MC38/HSV-tk cells (Figure 4c and d) . On the other hand, the effect of SFZ on IkBa phosphorylation and nuclear translocation of NFkB in wild-type MC38 cells was unclear (Figure 4) . Overall, these data indicate that treatment with SFZ results in the dose-dependent inhibition of NF-kB pathway activation caused by HSV-tk gene transduction.
Effect of SFZ on COX-2 expression and PGE 2 release In order to determine whether enhanced activation of NF-kB pathway in HSV-tk-transduced cells may account for upregulation of COX-2, we investigated the effect of pharmacological inhibition of NF-kB activity by SFZ on COX-2 expression and PGE 2 release in MC38 and MC38/ HSV-tk cells. Treatment of both MC38 and MC38/HSVtk cells with SFZ, at concentrations that were shown to inhibit NF-kB activity, led to dose-dependent decrease of COX-2 expression (Figure 5a ). At the maximal concentration of 1 mM, SFZ decreased COX-2 expression by 55% in MC38/HSV-tk cells and only by 34% in MC38 cells. Additionally, decreased levels of COX-2 in SFZtreated MC38 and MC38/HSV-tk cells were accompanied by the reduced release of PGE 2 into the culture medium (Figure 5b ). The fact that inhibition of NF-kB activity by SFZ was paralleled by the decreased expression of COX-2 suggests that NF-kB may be involved in the upregulation of COX-2 expression, previously observed in HSV-tktransduced cells.
Involvement of NF-kB in the transcriptional upregulation of COX-2 by HSV-tk gene transduction The involvement of NF-kB in the transcriptional upregulation of COX-2 by HSV-tk gene transduction was further investigated by analyzing the activity of COX-2 promoter, either wild type or mutated within the NF-kB binding site, in MC38 and MC38/HSV-tk cells. Two COX-2 promoter constructs fused to luciferase reporter gene were used (Figure 6a ). Figure 6b shows that HSV-tk gene transduction yielded a 4.4-fold increase in reporter activity in MC38/HSV-tk cells transiently transfected with wild-type COX-2 promoter construct, whereas mutation of NF-kB site of the COX-2 promoter resulted in a significant decrease of reporter activity in these cells. On the contrary, reporter activity in MC38 cells, transfected with either wild-type or mutated COX-2 promoter construct, was not affected by NF-kB site mutation (Figure 6b ). In order to further confirm these findings, we repeated this experiment using COS-7 cell line, which lacks endogenous COX-2 mRNA 43 and does not express COX-2 either before or after HSV-tk gene transduction (data not shown). Transient transfection of COS-7 and COS-7/HSV-tk cells with COX-2 promoter constructs yielded the same results as with MC38 and MC38/HSV-tk cells (Figure 6c ), confirming the involvement of NF-kB in COX-2 overexpression in HSV-tk-transduced cells.
Effect of HSV-tk gene transduction on NF-kB activity, COX-2 expression and PGE 2 release in 9L and T24 cells In order to clarify whether HSV-tk gene transduction may similarly affect NF-kB activity and COX-2 expression and activity in additional tumor cell lines, we monitored NF-kB activity, COX-2 expression and PGE 2 release in wild-type and HSV-tk-transduced 9L (rat gliosarcoma) and T24 (human urinary bladder cancer) cells. HSV-tk gene transduction caused significant enhancement of NF-kB activity in both 9L and T24 cells as confirmed by luciferase reporter gene assay using pNFkB-Luc (Figure 7a) . Likewise, HSV-tk gene transduction of both 9L and T24 cells resulted in the enhancement of COX-2 expression (Figure 7b ) and significant increase in PGE 2 release levels (Figure 7c ), nevertheless almost undetectable levels of COX-2 and considerably low levels of PGE 2 release in the respective wild-type cells. These data suggest that an enhancing effect of HSV-tk gene transduction on NF-kB activity and COX-2 expression is not limited to MC38 cells and persists in other tumor cell lines as well. 4 cells/well) and allowed to attach. Thereafter, cells were transiently transfected with pNFkB-Luc (1.5 mg/well) and 6 h later SFZ was added to the culture medium at the indicated concentrations. After 24 h, luciferase activity in cell lysates was measured and normalized to transfection efficiency as described in Materials and methods. Results were normalized to luciferase activity of nontreated wild-type MC38 cells. Data shown are means7s.e. (n ¼ 3). *Po0.05, MC38/HSV-tk SFZ-treated vs control.
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Discussion
In our previous study, we brought first evidence that transduction of murine colon cancer cells with HSV-tk gene, commonly used in cancer gene therapy, results in COX-2 overexpression and enhancement of tumor growth rate in vivo. 7 Based on the results of our previous experiments and the well-established significance of COX-2 expression for tumor growth and promotion, we have suggested that a possible causal relationship may exist between these observations. The question of molecular mechanism by which HSV-tk gene transduction upregulates COX-2 expression remained unsettled in that study. However, our preliminary findings showed that HSV-tk-transduced cells possess significantly enhanced activity of NF-kB, which is known to play an important role in the regulation of COX-2 expression. Thus, in the current report, we extended our observations by exploring in detail the effect of HSV-tk gene transduction on the activity of NF-kB pathway and possible involvement of this pathway in the upregulation of COX-2 expression in HSV-tk-transduced tumor cells.
Cumulative data indicate that persistent activation of the NF-kB pathway during the course of viral infection occurs via distinct molecular mechanisms, which are in many cases initiated upon the expression and/or activity of the specific viral proteins in the infected cell. 44 It has been reported, for example, that modulation of NF-kB activity by HIV-1, HTLV-1, hepatitis B virus (HBV), and Epstein-Barr virus (EBV) depends, at least in a part, on the ability of these viruses to express functionally active HIV-1 Tat, 45 HTLV-1 Tax, 46,47 HBV x protein, 48 and EBV latent membrane protein 1, 49 respectively. Similarly, HSV-1 has been shown to induce a constitutive activation of NF-kB, and two immediate-early (IE) proteins, ICP24 and ICP27, were found to be required for this effect. 50 Additional viral products and transforming proteins that have been identified as potent inducers of NF-kB activity include hepatitis C virus core protein, 51 cytomegalovirus IE1-72, IE2-55 and -IE2-86, 52 adenovirus encoded E3 
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and others. 54 In these studies, the effect of the specific viral protein on the activity of NF-kB pathway within the target cell was monitored under various experimental conditions, which involved either viral infection of cells with genetically modified virus or transgene delivery through stable or transient transfection with viral vector or plasmid DNA. In our study, we have demonstrated that NF-kB transcriptional activity was upregulated in MC38 cells stably transduced with HSV-tk gene using a retroviral vector (Figure 1 ). The question of whether upregulation of NF-kB activity was mediated by the presence of HSV-tk DNA or by enzymatic activity of the HSV-tk product remained beyond the scope of the current study. However, our findings indicate that the observed In pGL3C2-C1 construct, luciferase expression is driven by wild-type (966/ þ 23) COX-2 promoter. In pGL3C2-C7, NF-kB consensus sequence of the COX-2 promoter was changed from GGGGATTCCC to GGGCCTTCCC. Effect of mutation within NF-kB binding site on the activity of COX-2 in transiently transfected (b) MC38 and MC38/HSV-tk cells and (c) COS-7 and COS-7/HSV-tk cells. Cells were seeded in six-well culture plates (15 Â 10 4 cells/well) and allowed to attach. Thereafter, cells were transiently transfected with either pGL3C2-C1 or pGL3C2-C7 (2 mg/well) and 48 h later, luciferase activity in cell lysates was measured and normalized to transfection efficiency as described in Materials and methods. Results were normalized to luciferase activity of wild-type cells transfected with pGL3C2-C1. Data shown are means7s.e. (n ¼ 3). *Po0.05, pGL3C2-C7 vs pGL3C2-C1.
NF-jB upregulates COX-2 in HSV-tk-transduced cells A Konson et al effect appears to be HSV-tk-specific, as transduction of MC38 cells with control LNL6 vector, which only differs from STK vector by lacking HSV-tk sequence, did not significantly affect NF-kB activity (Figure 1) .
It is well established that NF-kB pathway may be differentially transactivated by various signal transduction pathways, whereas most of them converge on the activation of IKK signalosome complex. 55 Furthermore, in addition to the canonical NF-kB pathway, which proceeds downstream to IKK and involves phosphorylation and degradation of IkB and translocation of NF-kB complex to the nucleus, at least one alternative pathway has been identified recently. 56 This evolutionarily conserved pathway is based on IKKa-dependent regulation of NF-kB2 (p100) precursor processing rather than IkB degradation. A variety of other signaling events, including phosphorylation of p65 and de novo synthesis of IkBs, provide mechanisms of modulating the amount and duration of NF-kB activity. 57 It is therefore reasonable to suggest that identification of the specific NF-kB-related intracellular events that resulted in the enhancement of NF-kB transcriptional activity may have particular importance when choosing a strategy for pharmacological inhibition of NF-kB activity. In this context, we have shown that HSV-tk gene transduction yielded a significant increase in IkBa phosphorylation and degradation paralleled by enhanced p65 expression in the nucleus of MC38/HSV-tk cells as compared to the relatively low levels of phosphorylated IkkBa and nuclear p65 in MC38 cells, which nevertheless are present and suggest a basal level of NF-kB activity (Figure 2 ). It may therefore be suggested that increased NF-kB transcriptional activity in MC38/HSV-tk cells was presumably caused by increased phosphorylation and degradation of IkB and enhanced nuclear translocation of the freed NF-kB complex.
Although we provided evidence showing enhanced activation of NF-kB in HSV-tk-transduced MC38 cells, the exact mechanisms mediating the HSV-tk-induced activation of NF-kB are still unclear. At present, we cannot say whether activation of NF-kB pathway in HSV-tk-transduced cells was caused by the direct effect of HSV-tk on the activity of certain NF-kB-related protein/s or, alternatively, NF-kB was transactivated by other signal transduction pathways triggered by HSV-tk gene transduction. Additional studies, involving pathway screening arrays and protein-protein interaction experiments, are needed to elucidate the exact molecular mechanism of NF-kB activation by HSV-tk.
Extending our observations to understand whether the described enhancement of NF-kB activity may account for the previously observed COX-2 overexpression in MC38/HSV-tk cells, we first used a pharmacological 
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A Konson et al approach. For this purpose, we monitored COX-2 expression in MC38 and MC38/HSV-tk cells treated with NF-kB inhibitor, SFZ. SFZ has been previously reported to block nuclear translocation of NF-kB complexes at concentrations of 0.1-5 mM by interfering with IkB phosphorylation and inhibiting its successive degradation. 58, 59 It has also been suggested that inhibition of NF-kB activation by SFZ appears to be specific as other DNA-binding activities were not affected. 58 Under our experimental conditions, treatment of both MC38 and MC38/HSV-tk cells with SFZ caused dose-dependent inhibition of NF-kB transcriptional activity (Figure 3) , which was associated with prevention of IkB phosphorylation and degradation, and successive retention of NF-kB complexes in the cytosol (Figure 4) . We also demonstrated that inhibition of NF-kB activity by SFZ was accompanied by a dose-dependent decrease in COX-2 expression (Figure 5a ) and the subsequent reduction in PGE 2 release (Figure 5b ) in both MC38 and MC38/HSVtk cells. These findings suggest that NF-kB may be involved in the transcriptional regulation of COX-2 expression in these cells. It should be emphasized, however, that an inhibitory effect of SFZ on NF-kB activity and on COX-2 expression was more substantial in MC38/HSV-tk cells. This outcome is consistent with our previous findings that demonstrated possible lack of NFkB involvement in COX-2 expression in wild-type MC38 cells. 60 Thus, NF-kB may not be as essential for the basal COX-2 expression in wild-type cells as for upregulation of COX-2 expression caused by HSV-tk gene transduction. Alternatively, these findings may be also explained by comparatively low basal levels of NF-kB activity in wildtype MC38 cells.
In order to clarify the role of NF-kB in the transcriptional upregulation of COX-2 by HSV-tk gene transduction, we evaluated the requirement of the preserved NF-kB binding site for the activation of COX-2 promoter in MC38 and MC38/HSV-tk cells. It has been shown that several consensus cis-elements in the 5 0 -flanking region of the COX-2 gene, including a CRE motif, AP1 and NF-kB binding sites, an NF-IL6 motif and an E-box, provide transcriptional control of COX-2 expression either independently or synergistically. 61 Numerous studies used site-directed mutagenesis of the NF-kB consensus sequence within the COX-2 promoter to demonstrate the particular importance of NF-kB for transcriptional regulation of COX-2 expression in a variety of experimental systems. 62, 63 In this study, we employed two COX-2 promoter constructs, which were cloned into luciferase expression vector and contained either native COX-2 promoter or COX-2 promoter with mutated NF-kB site. Presence of the functionally inactive, mutated NF-kB site within transiently expressed COX-2 promoter construct resulted in significant inhibition of reporter activity in MC38/HSV-tk cells as compared with reporter activity in MC38/HSV-tk cells transfected with wild-type COX-2 promoter construct (Figure 6b ). On the other hand, COX-2 promoter activity in MC38 cells was not affected by the mutation in NF-kB binding site (Figure 6b ). These results not only provide direct evidence for the involvement of NF-kB in the transcriptional upregulation of COX-2 by HSV-tk, but also may support our earlier suggestion that NF-kB is not essential for basal COX-2 expression in wild-type MC38 cells. It should be noticed that transient transfection of MC38/HSV-tk cells with COX-2 promoter construct containing mutated NF-kB site did not result in the reduction of reporter activity to a level similar to that of MC38 cells (Figure 6b ), indicating that additional transcriptional regulators may be involved in the upregulation of COX-2 expression in MC38/HSV-tk cells.
We further confirmed our findings by performing similar experiment in African green monkey kidney cells (COS-7). COS-7 cell line may provide a better model for studying activation of the cloned COX-2 promoter, as these cells have been previously reported to lack endogenous COX-2 mRNA. 43 In agreement with this, our own previous experiments revealed that COS-7 cells do not express detectable COX-2 protein and do not produce PGE 2 , even upon exogenous addition of arachidonic acid, either before or after HSV-tk gene transduction (data not shown). Transient transfection of COS-7 and COS-7/HSV-tk cells with wild-type COX-2 promoter construct showed that HSV-tk gene transduction results in significant enhancement of reporter activity (Figure 6c ), suggesting activation of the signal transduction pathway/s that controls COX-2 promoter activity. Similar to the experiment with MC38 cells, mutation within the NF-kB binding site of COX-2 promoter decreased reporter activity in COS-7/HSV-tk cells and did not affect that of wild-type COS-7 cells (Figure 6c ). These data confirm that transcriptional upregulation of COX-2 expression by HSV-tk gene transduction occurs via activation of NF-kB pathway.
Finally, we aimed to corroborate our findings by evaluating whether HSV-tk gene transduction may similarly affect NF-kB activity and COX-2 expression in additional tumor cell lines. Thus, we monitored the effect of HSV-tk gene transduction on NF-kB activity and COX-2 expression in rat gliosarcoma (9L) and human urinary bladder cancer (T24) cells. As shown in Figure 7 , HSV-tk gene transduction of both 9L and T24 cells resulted in significantly enhanced NF-kB activity (Figure 7a ) and COX-2 expression (Figure 7b ) with subsequent increase in PGE 2 levels (Figure 7c ) as expected. These data, together with the well-established role of NF-kB in the transcriptional upregulation of COX-2 expression, support our assumption that NF-kB is involved in COX-2 overexpression in these cells in the same way as in HSV-tk-transduced MC38 cells.
In summary, the current report demonstrates enhanced activation of NF-kB pathway by HSV-tk gene transduction and establishes an essential role for NF-kB in the upregulation of COX-2 expression in HSV-tk-transduced cells. Several lines of evidence that suggest significance of NF-kB activation for carcinogenesis and tumor promotion, together with our results, provide rationale for combining HSV-tk/GCV therapy with NF-kB inhibition. Indeed, a recent study by Moriuchi et al. 64 showed that coexpression of HSV-tk with IkB mutant that was incapable of phosphorylation improved the efficacy of HSV-tk/GCV therapy for glioblastoma in vitro and in vivo. However, the issue of COX-2 overexpression and increased growth rate of HSV-tk-expressing tumors was not addressed in this study. Ongoing research in our laboratory is currently testing several approaches to inhibit NF-kB activity in conjunction with HSV-tk/ GCV therapy in vivo and will definitely bring deeper insight into possible therapeutic benefits of this strategy.
